{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:21:40Z","timestamp":1762100500671},"reference-count":33,"publisher":"Japanese Society of Hypertension","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1291\/hypres.28.917","type":"journal-article","created":{"date-parts":[[2006,5,30]],"date-time":"2006-05-30T05:55:10Z","timestamp":1148968510000},"page":"917-924","source":"Crossref","is-referenced-by-count":35,"title":["Thiazolidinedione Effects on Blood Pressure in Diabetic Patients with Metabolic Syndrome Treated with Glimepiride"],"prefix":"10.1291","volume":"28","author":[{"given":"Giuseppe","family":"DEROSA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo Francesco Giuseppe","family":"CICERO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D'ANGELO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"GADDI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Dario","family":"RAGONESI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Nello","family":"PICCINNI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibilla","family":"SALVADEO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardina","family":"CICCARELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"PRICOLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morena","family":"GHELFI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"FERRARI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"MONTAGNA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"FOGARI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: American Diabetes Association: clinical practice recommendations 2002. <i>Diabetes Care<\/i> 2002; <b>25<\/b> (Suppl): S1-S147.","DOI":"10.2337\/diacare.25.2007.S5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Charpentier G, Fleury F, Kabir M, Vaur L, Halimi S: Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients. <i>Diabet Med<\/i> 2001; <b>18<\/b>: 828-834.","DOI":"10.1046\/j.1464-5491.2001.00582.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Riddle M: Combining sulfonylureas and other oral agents. <i>Am J Med<\/i> 2000; <b>108<\/b> (Suppl 6a): 15S-22S.","DOI":"10.1016\/S0002-9343(00)00338-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. McCall AL: Clinical review of glimepiride. <i>Expert Opin Pharmacother<\/i> 2001; <b>2<\/b>: 699-713.","DOI":"10.1517\/14656566.2.4.699"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ovalle F, Ovalle-Ber&uacute;men JF: Thiazolidinediones: a review of their benefits and risks. <i>South Med J<\/i> 2002; <b>95<\/b>: 1187-1194.","DOI":"10.1097\/00007611-200210000-00016"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00224.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vongthavaravat V, Wajchenberg BL, Waitman JN, <i>et al<\/i>, 125 Study Group: An international study of the effects of rosiglitazone plus sulphonylurea in patients with type 2 diabetes. <i>Curr Med Res Opin<\/i> 2002; <b>18<\/b>: 456-461.","DOI":"10.1185\/030079902125001236"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. St John Sutton M, Rendell M, Dandona P, <i>et al<\/i>: A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. <i>Diabetes Care<\/i> 2002; <b>25<\/b>: 2058-2064.","DOI":"10.2337\/diacare.25.11.2058"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pavo I, Jermendy G, Varkonyi TT, <i>et al<\/i>: Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes. <i>J Clin Endocrinol Metab<\/i> 2003; <b>88<\/b>: 1637-1645.","DOI":"10.1210\/jc.2002-021786"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Derosa G, Cicero AFG, Gaddi A, <i>et al<\/i>: Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. <i>Clin Ther<\/i> 2004; <b>26<\/b>: 744-754.","DOI":"10.1016\/S0149-2918(04)90074-4"},{"key":"12","unstructured":"12. American Diabetes Association: Nutrition recommendations and principles for people with diabetes mellitus (position statement). <i>Diabetes Care<\/i> 2001; <b>24<\/b> (1): S44-S47."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. American Diabetes Association: Screening for diabetes (position statement). <i>Diabetes Care<\/i> 2001; <b>24<\/b> (1): S21-S24.","DOI":"10.2337\/diacare.25.2007.S21"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917020-00001"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bunn HF, Gabbay HK, Gallop PM: The glycosylation of haemoglobin. Relevance to diabetes mellitus. <i>Science<\/i> 1978; <b>200<\/b>: 21-27.","DOI":"10.1126\/science.635569"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. European Diabetes Policy Group: A desktop guide to type 2 diabetes mellitus. <i>Diabet Med<\/i> 1999; <b>16<\/b>: 716-730.","DOI":"10.1046\/j.1464-5491.1999.00166.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Heding LG: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. <i>Diabetologia<\/i> 1972; <b>8<\/b>: 260-266.","DOI":"10.1007\/BF01225569"},{"key":"19","unstructured":"19. Winer BJ: Statistical Principles in Experimental Design, 2nd ed. New York, McGraw-Hill, 1971."},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vivian EM, Rubinstein GB: Pharmacologic management of diabetic nephropathy. <i>Clin Ther<\/i> 2002; <b>24<\/b>: 1741-1756.","DOI":"10.1016\/S0149-2918(02)80076-5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Katayama S, Inaba M, Morita T, Awata T, Shimamoto K, Kikkawa R: Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus. <i>Hypertens Res<\/i> 2000; <b>23<\/b>: 601-605.","DOI":"10.1291\/hypres.23.601"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.281"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.669"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.795"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Harano Y, Suzuki M, Shinozaki K, <i>et al<\/i>: Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach. <i>Hypertens Res<\/i> 1996; <b>9<\/b> (Suppl 1): S81-S85.","DOI":"10.1291\/hypres.19.SupplementI_S81"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.457"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Boyle PJ, King AB, Olansky L, <i>et al<\/i>: Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records. <i>Clin Ther<\/i> 2002; <b>24<\/b>: 378-396.","DOI":"10.1016\/S0149-2918(02)85040-8"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.307"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kanbay M, Yildirir A, Bozbas H, <i>et al<\/i>: Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. <i>Ren Fail<\/i> 2005; <b>27<\/b>: 297-303.","DOI":"10.1081\/JDI-200056610"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shargorodsky M, Wainstein G, Gavish E, Leibovitz Z, Matas D, Zimlichman R: Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus. <i>Am J Hypertens<\/i> 2003; <b>16<\/b>: 617-622.","DOI":"10.1016\/S0895-7061(03)00911-7"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fullert S, Schneider F, Haak E, <i>et al<\/i>: Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. <i>J Clin Endocrinol Metab<\/i> 2002; <b>87<\/b>: 5503-5506.","DOI":"10.1210\/jc.2002-020963"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Derosa G, Mugellini A, Ciccarelli L, Crescenzi G, Fogari R: Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors. <i>Clin Ther<\/i> 2003; <b>25<\/b>: 472-484.","DOI":"10.1016\/S0149-2918(03)80090-5"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T02:16:00Z","timestamp":1555640160000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.28.917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.28.917","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}